vs

Side-by-side financial comparison of CAMTEK LTD (CAMT) and MYERS INDUSTRIES INC (MYE). Click either name above to swap in a different company.

CAMTEK LTD is the larger business by last-quarter revenue ($242.0M vs $204.0M, roughly 1.2× MYERS INDUSTRIES INC). CAMTEK LTD runs the higher net margin — 28.1% vs 5.6%, a 22.6% gap on every dollar of revenue.

Camtek Ltd is a leading global developer and manufacturer of high-precision inspection and metrology systems for the semiconductor, printed circuit board, and advanced packaging industries. Its solutions support process control, defect detection, and yield optimization for clients across Asia, North America, and Europe.

Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban (Eliquis) for people with atrial fibrillation ; nivolumab (Opdivo), used to treat certain types of cancer ; lenalidomide (Revlimid), used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes ; abatacept (Orencia), used to treat autoimmune diseases such as rheumatoid ...

CAMT vs MYE — Head-to-Head

Bigger by revenue
CAMT
CAMT
1.2× larger
CAMT
$242.0M
$204.0M
MYE
Higher net margin
CAMT
CAMT
22.6% more per $
CAMT
28.1%
5.6%
MYE

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
CAMT
CAMT
MYE
MYE
Revenue
$242.0M
$204.0M
Net Profit
$68.0M
$11.3M
Gross Margin
50.9%
33.2%
Operating Margin
26.7%
9.9%
Net Margin
28.1%
5.6%
Revenue YoY
0.0%
Net Profit YoY
163.7%
EPS (diluted)
$0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAMT
CAMT
MYE
MYE
Q4 25
$204.0M
Q3 25
$205.4M
Q2 25
$242.0M
$209.6M
Q1 25
$206.8M
Q4 24
$203.9M
Q3 24
$205.1M
Q2 24
$199.6M
$220.2M
Q1 24
$207.1M
Net Profit
CAMT
CAMT
MYE
MYE
Q4 25
$11.3M
Q3 25
$7.1M
Q2 25
$68.0M
$9.7M
Q1 25
$6.8M
Q4 24
$4.3M
Q3 24
$-10.9M
Q2 24
$52.8M
$10.3M
Q1 24
$3.5M
Gross Margin
CAMT
CAMT
MYE
MYE
Q4 25
33.2%
Q3 25
33.4%
Q2 25
50.9%
33.7%
Q1 25
33.4%
Q4 24
32.3%
Q3 24
31.8%
Q2 24
48.1%
34.3%
Q1 24
31.0%
Operating Margin
CAMT
CAMT
MYE
MYE
Q4 25
9.9%
Q3 25
8.6%
Q2 25
26.7%
9.5%
Q1 25
8.1%
Q4 24
7.2%
Q3 24
-2.3%
Q2 24
23.6%
10.8%
Q1 24
5.3%
Net Margin
CAMT
CAMT
MYE
MYE
Q4 25
5.6%
Q3 25
3.5%
Q2 25
28.1%
4.6%
Q1 25
3.3%
Q4 24
2.1%
Q3 24
-5.3%
Q2 24
26.4%
4.7%
Q1 24
1.7%
EPS (diluted)
CAMT
CAMT
MYE
MYE
Q4 25
$0.30
Q3 25
$0.19
Q2 25
$0.26
Q1 25
$0.18
Q4 24
$0.11
Q3 24
$-0.29
Q2 24
$0.28
Q1 24
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAMT
CAMT
MYE
MYE
Cash + ST InvestmentsLiquidity on hand
$232.0M
$45.0M
Total DebtLower is stronger
$345.8M
Stockholders' EquityBook value
$626.5M
$294.2M
Total Assets
$974.7M
$851.3M
Debt / EquityLower = less leverage
1.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAMT
CAMT
MYE
MYE
Q4 25
$45.0M
Q3 25
$48.0M
Q2 25
$232.0M
$41.3M
Q1 25
$35.3M
Q4 24
$32.2M
Q3 24
$29.7M
Q2 24
$109.8M
$37.3M
Q1 24
$32.7M
Total Debt
CAMT
CAMT
MYE
MYE
Q4 25
$345.8M
Q3 25
$361.2M
Q2 25
$370.8M
Q1 25
$383.4M
Q4 24
$375.0M
Q3 24
$387.5M
Q2 24
$400.1M
Q1 24
$400.6M
Stockholders' Equity
CAMT
CAMT
MYE
MYE
Q4 25
$294.2M
Q3 25
$286.6M
Q2 25
$626.5M
$284.6M
Q1 25
$277.4M
Q4 24
$277.5M
Q3 24
$275.6M
Q2 24
$475.4M
$294.6M
Q1 24
$291.7M
Total Assets
CAMT
CAMT
MYE
MYE
Q4 25
$851.3M
Q3 25
$864.1M
Q2 25
$974.7M
$862.7M
Q1 25
$883.8M
Q4 24
$860.8M
Q3 24
$905.0M
Q2 24
$796.2M
$951.6M
Q1 24
$947.1M
Debt / Equity
CAMT
CAMT
MYE
MYE
Q4 25
1.18×
Q3 25
1.26×
Q2 25
1.30×
Q1 25
1.38×
Q4 24
1.35×
Q3 24
1.41×
Q2 24
1.36×
Q1 24
1.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CAMT
CAMT
MYE
MYE
Operating Cash FlowLast quarter
$47.1M
$22.6M
Free Cash FlowOCF − Capex
$18.9M
FCF MarginFCF / Revenue
9.3%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
0.69×
1.99×
TTM Free Cash FlowTrailing 4 quarters
$67.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CAMT
CAMT
MYE
MYE
Q4 25
$22.6M
Q3 25
$25.8M
Q2 25
$47.1M
$28.3M
Q1 25
$10.1M
Q4 24
$27.3M
Q3 24
$17.3M
Q2 24
$70.1M
$14.3M
Q1 24
$20.3M
Free Cash Flow
CAMT
CAMT
MYE
MYE
Q4 25
$18.9M
Q3 25
$21.5M
Q2 25
$24.7M
Q1 25
$2.0M
Q4 24
$20.2M
Q3 24
$10.1M
Q2 24
$9.9M
Q1 24
$14.6M
FCF Margin
CAMT
CAMT
MYE
MYE
Q4 25
9.3%
Q3 25
10.5%
Q2 25
11.8%
Q1 25
1.0%
Q4 24
9.9%
Q3 24
4.9%
Q2 24
4.5%
Q1 24
7.0%
Capex Intensity
CAMT
CAMT
MYE
MYE
Q4 25
1.8%
Q3 25
2.1%
Q2 25
1.7%
Q1 25
3.9%
Q4 24
3.5%
Q3 24
3.5%
Q2 24
2.0%
Q1 24
2.8%
Cash Conversion
CAMT
CAMT
MYE
MYE
Q4 25
1.99×
Q3 25
3.63×
Q2 25
0.69×
2.92×
Q1 25
1.49×
Q4 24
6.36×
Q3 24
Q2 24
1.33×
1.40×
Q1 24
5.79×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CAMT
CAMT

Segment breakdown not available.

MYE
MYE

Industrial$64.3M32%
Auto Aftermarket$51.7M25%
Infrastructure$34.0M17%
Food And Beverage$23.2M11%
Vehicle$17.9M9%
Consumer$12.9M6%

Related Comparisons